This preview has intentionally blurred sections. Sign up to view the full version.View Full Document
Unformatted text preview: 2. Why is it important to have a variety of people enrolled in clinical trials? 3. Define each of the terms using the text. (They are not all in one place – read through the end.) a. Inclusion / exclusion criteria b. Protocol c. placebo 4. List the major differences between Phase I, Phase II, and Phase III clinical trials. You may use a chart if you wish, but please be clear about what you are saying. 5. Read through the text and list all the ways a patient is protected during a clinical trial. Consider their privacy, safety, health, etc. 6. Explain why double-blind studies are critical in evaluating the results of a clinical trial. 7. Read the paragraph “Identifying Important Variables” in section 1.6 in your textbook. Suppose you were to investigate the effect of a Drug X on the occurrence of heart attacks. List all the possible variables that would have to be identical between the control group and the experimental group....
View Full Document
- Spring '08
- Biology, Clinical trial, US Food & Drug Administration